Differential regulation of monocytic tumor necrosis factor‐α and interleukin‐10 expression
- 1 July 1996
- journal article
- research article
- Published by Wiley in European Journal of Immunology
- Vol. 26 (7) , 1580-1586
- https://doi.org/10.1002/eji.1830260726
Abstract
Activation of human monocytes by bacterial endotoxin (LPS) results in an initial burst of inflammatory cytokines like tumor necrosis factor (TNF)‐α which is followed by the secretion of anti‐inflammatory mediators like interleukin (IL)‐10. The signaling pathways in IL‐10 induction are unknown. Here, we show that the regulation of IL‐10 expression is more complex than that of TNF‐α. LPS‐induced TNF‐α and IL‐10 expression requires early activation of protein tyrosine kinases (PTK). Moreover, delayed addition of PTK inhibitors blocked IL‐10, but not TNF‐α, suggesting the impact of a late PTK activity. Two inducers of PTK activity are the downstream mediators of LPS activation, TNF‐α and cyclic adenosine monophosphate (cAMP). Both mediators synergistically up‐regulate IL‐10 expression. Downstream of PTK activation, they use distinct pathways. TNF‐α, but not cAMP‐induced IL‐10 gene expression was inhibited by pyrrolidine dithiocarbamate, suggesting the involvement of reactive oxygen species. Inhibition of protein kinase C (PKC) suppressed LPS‐induced TNF‐α and IL‐10 expression as well, but, unlike TNF‐α, direct activation of PKC by phorbol 12‐myristate 13‐acetate (PMA) did not induce IL‐10 expression. Furthermore, PKC is not involved in late events of IL‐10 activation, as delayed addition of PKC inhibitors did not suppress LPS‐induced IL‐10 expression and did not influence cAMP‐ or TNF‐α‐induced IL‐10. The modulation of IL‐10 expression by inflammatory mediators suggests a regulatory circuit of the inflammatory response.Keywords
This publication has 27 references indexed in Scilit:
- Stimulation of the Human Cytomegalovirus IE Enhancer/Promoter in HL-60 Cells by TNFα Is Mediated via Induction of NF-κBVirology, 1995
- Up-regulation of monocytic IL-10 by tumor necrosis factor-α and cAMP elevating drugsInternational Immunology, 1995
- Regulation of interleukin 10 release by tumor necrosis factor in humans and chimpanzees.The Journal of Experimental Medicine, 1994
- QUANTITATIVE PCR ANALYSIS OF CYTOKINE TRANSCRIPTION PATTERNS IN PERIPHERAL MONONUCLEAR CELLS AFTER ANTI-CD3 REJECTION THERAPY USING TWO NOVEL MULTISPECIFIC COMPETITOR FRAGMENTS1Transplantation, 1994
- Lipopolysaccharide‐induced cytokine production in human monocytes: Role of tyrosine phosphorylation in transmembrane signal transductionEuropean Journal of Immunology, 1994
- Prevention of Lipopolysaccharide-Induced Lethal Toxicity by Tyrosine Kinase InhibitorsScience, 1994
- 5′ Noncoding sequence of human IL-10 gene obtained by oligo-cassette PCR walkingDNA Sequence, 1994
- EVIDENCE THAT PENTOXIFYLLINE REDUCES ANTI-CD3 MONOCLONAL ANTIBODY-INDUCED CYTOKINE RELEASE SYNDROMETransplantation, 1991
- Effects of Pretreatment with Protein Kinase C Activators on Macrophage Activation for Tumor Cytotoxicity, Secretion of Tumor Necrosis Factor, and Its mRNA ExpressionImmunobiology, 1989
- Camp inhibits the okt3‐ induced increase in cytoplasmic free calcium in the jurkat t cell line: the degree of inhibition correlates inversely with the amount of cd3 binding ligand used*European Journal of Immunology, 1989